Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Enrolling by invitation No phase listed Observational

Global Utilization And Registry Database for Improved preservAtion of doNor Livers

ClinicalTrials.gov ID: NCT05082077

Public ClinicalTrials.gov record NCT05082077. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 9:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Global Utilization and Registry Database for Improved Preservation of Donor Livers

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this registry is to collect and evaluate various clinical effectiveness parameters in patients with transplanted donor liver that were preserved and transported within the LIVERguard system, as well as retrospective standard of care patients

Study identification

NCT ID
NCT05082077
Recruitment status
Enrolling by invitation
Study type
Observational
Phase
Not listed
Lead sponsor
Paragonix Technologies
Industry
Enrollment
2,000 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 15, 2022 (Actual)
Primary completion
Aug 2027 (Estimated)
Completion
Jan 2028 (Estimated)
Last update posted
Sep 17, 2026

2022 – 2028

United States locations

U.S. sites
15
U.S. states
12
U.S. cities
15
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233 —
University of California San Diego San Diego California 92093-0990 —
Stanford University Stanford California 94305 —
University of Florida Gainesville Florida 32608 —
Mayo Clinic Jacksonville Jacksonville Florida 32224 —
Tampa General Hospital Tampa Florida 33606 —
Piedmont Healthcare Atlanta Georgia 30309 —
University of Maryland, Baltimore Baltimore Maryland 21201 —
Lahey Clinic Burlington Massachusetts 01805 —
University of Nebraska Omaha Nebraska 68198 —
Duke University Durham North Carolina 27710 —
University of Cincinnati Cincinnati Ohio 45221 —
University of Texas Health Science Center at San Antonio San Antonio Texas 78229-3901 —
Intermountain Health Center Salt Lake City Utah 84111 —
University of Washington Seattle Washington 98109 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05082077, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 17, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05082077 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →